Literature DB >> 1538220

Thiamine status in inherited degenerative ataxias.

O L Pedraza1, M I Botez.   

Abstract

Blood thiamine levels in ataxia patients were studied. No significant differences were found between 30 patients with Friedreich's ataxia and 29 patients with olivopontocerebellar atrophy (OPCA) compared with control subjects. Both OPCA and Friedreich's ataxia patients presented significantly lower cerebrospinal fluid thiamine levels than their controls (p less than 0.001 and p less than 0.04 respectively). These results, discussed in terms of the high degree of cerebellar atrophy on CT scans in OPCA v Friedreich's ataxia patients, seem to correlate with cerebellar thiamine turnover and content.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538220      PMCID: PMC488978          DOI: 10.1136/jnnp.55.2.136

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

Review 1.  Thiamin and the brain.

Authors:  R H Haas
Journal:  Annu Rev Nutr       Date:  1988       Impact factor: 11.848

2.  Cerebellar degeneration in thiamine-deficient rats.

Authors:  G H Collins; W K Converse
Journal:  Am J Pathol       Date:  1970-02       Impact factor: 4.307

3.  Distribution of thiamine phosphate esters in normal and thiamine-deficient brain.

Authors:  J H Pincus; I Grove
Journal:  Exp Neurol       Date:  1970-09       Impact factor: 5.330

4.  Morphological changes of olivopontocerebellar atrophy in computed tomography and comments on its pathogenesis.

Authors:  Y P Huang; A Plaitakis
Journal:  Adv Neurol       Date:  1984

5.  Kinetics of thiamine transport across the blood-brain barrier in the rat.

Authors:  J Greenwood; E R Love; O E Pratt
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

6.  Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.

Authors:  M I Botez; S N Young
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

7.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

Authors:  A E Harding
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

8.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  J P Bouchard; A Barbeau; R Bouchard; R W Bouchard
Journal:  Can J Neurol Sci       Date:  1978-02       Impact factor: 2.104

9.  Thiamine content and turnover rates of some rat nervous regions, using labeled thiamine as a tracer.

Authors:  G Rindi; C Patrini; V Comincioli; C Reggiani
Journal:  Brain Res       Date:  1980-01-13       Impact factor: 3.252

10.  Intermittent thiamine deficiency in the rhesus monkey. I. Progression of neurological signs and neuroanatomical lesions.

Authors:  E D Witt; P S Goldman-Rakic
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  6 in total

1.  Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Authors:  Antonio Costantini; Tiziana Laureti; Maria Immacolata Pala; Marco Colangeli; Simona Cavalieri; Elisa Pozzi; Alfredo Brusco; Sandro Salvarani; Carlo Serrati; Roberto Fancellu
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

2.  Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region.

Authors:  I Lopes-Cendes; E Andermann; E Attig; F Cendes; S Bosch; M Wagner; F Gerstenbrand; F Andermann; G A Rouleau
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

3.  Thiamine and spinocerebellar ataxia type 2.

Authors:  Antonio Costantini; Maria Immacolata Pala; Marco Colangeli; Serena Savelli
Journal:  BMJ Case Rep       Date:  2013-01-10

4.  High-dose thiamine improves the symptoms of Friedreich's ataxia.

Authors:  Antonio Costantini; Rafaela Giorgi; Sonia D'Agostino; Maria Immacolata Pala
Journal:  BMJ Case Rep       Date:  2013-05-22

Review 5.  Antioxidant Therapies and Oxidative Stress in Friedreich´s Ataxia: The Right Path or Just a Diversion?

Authors:  Laura R Rodríguez; Tamara Lapeña; Pablo Calap-Quintana; María Dolores Moltó; Pilar Gonzalez-Cabo; Juan Antonio Navarro Langa
Journal:  Antioxidants (Basel)       Date:  2020-07-24

Review 6.  Drug Repositioning in Friedreich Ataxia.

Authors:  Alessandra Rufini; Florence Malisan; Ivano Condò; Roberto Testi
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.